Arcus Biosciences Inc Domvanalimab Program Update Transcript
Good afternoon, ladies and gentlemen. My name is Loya, and I will be your operator on this call.
(Operator Instructions) Please note that this call is being recorded today, Wednesday, June 23, 2021, at 2:00 p.m. Pacific Time; and will be available on the investors section of Arcus' website at www.arcusbio.com.
I would now like to turn the meeting over to Kaytee Bock, Vice President of Investor Relations and Corporate Strategy from Arcus.
Please go ahead, ma'am.
Thank you. Hi, everyone. Thank you, Loya. And thank you all for participating in today's call on such short notice.
Today, we will be discussing this afternoon's announcement regarding the interim analysis from the ARC-7 study. Joining me from Arcus are Terry Rosen, Chief Executive Officer; Juan Jaen, President; Jennifer Jarrett, Chief Operating Officer; Bill Grossman, Chief Medical Officer; and Kartik Krishnan, Senior Vice
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |